发布求助
文献互助 智能选刊 最新文献

Current Treatment Options in Allergy最新文献

筛选
英文 中文
Triggers of Anaphylaxis in Mastocytosis Patients: Evidence of the Current Drug-Avoidance Recommendation 肥大细胞增多症患者过敏反应的诱因:当前药物避免建议的证据
Current Treatment Options in Allergy Pub Date : 2023-09-20 DOI: 10.1007/s40521-023-00349-2
Tiago Azenha Rama, Mariana Castells
{"title":"Triggers of Anaphylaxis in Mastocytosis Patients: Evidence of the Current Drug-Avoidance Recommendation","authors":"Tiago Azenha Rama, Mariana Castells","doi":"10.1007/s40521-023-00349-2","DOIUrl":"https://doi.org/10.1007/s40521-023-00349-2","url":null,"abstract":"Opinion statement Mastocytosis is associated with a high risk of anaphylaxis, in part due to drug hypersensitivity reactions (DHR). Drugs associated with mast cell activation include nonsteroidal anti-inflammatory drugs (NSAIDs), drugs used in the perioperative setting, including general anesthetics, neuromuscular blocking agents (NMBAs) and opiates/opioids, radiocontrast media (RCM), vaccines, and antibiotics such as quinolones and vancomycin. To protect patients against DHR and anaphylaxis, general avoidance of potential drug triggers is common practice, which often deprives patients of important drugs at times of need and limits their options. We aimed to critically review current evidence on the indications to avoid drugs in children and adults with mastocytosis. Recent data shows that general avoidance of drugs with potential mast cell activation action is not indicated in all patients with mastocytosis, but guidelines are lacking. Drugs tolerated before and after the onset of mastocytosis should not be avoided and a personalized approach is recommended to address drugs inducing mast cell activation. Pre-medication (RCM, local and general anesthetics, vaccines), use of safer alternatives (opioids, NBMAs, NSAIDs in selected cases), and drug challenges (NSAIDs in most cases) are recommended to increase the safety of patients with mastocytosis when introduced to new drugs.","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136306959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Respiratory Exposure Tests in Aspirin Exacerbated Respiratory Disease 阿司匹林加重呼吸道疾病的呼吸道暴露试验
IF 1.1
Current Treatment Options in Allergy Pub Date : 2023-08-30 DOI: 10.1007/s40521-023-00346-5
I. Bobolea, N. Rubira, J. Mullol
{"title":"Respiratory Exposure Tests in Aspirin Exacerbated Respiratory Disease","authors":"I. Bobolea, N. Rubira, J. Mullol","doi":"10.1007/s40521-023-00346-5","DOIUrl":"https://doi.org/10.1007/s40521-023-00346-5","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45999214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimising the Utility of In Vitro Tests for the Diagnosis of Drug Allergy: Insights from a Clinical Perspective 优化体外试验在药物过敏诊断中的应用：从临床角度的见解
IF 1.1
Current Treatment Options in Allergy Pub Date : 2023-07-11 DOI: 10.1007/s40521-023-00345-6
Marina Sabaté-Brescó, P. Quan, M. J. Goikoetxea
{"title":"Optimising the Utility of In Vitro Tests for the Diagnosis of Drug Allergy: Insights from a Clinical Perspective","authors":"Marina Sabaté-Brescó, P. Quan, M. J. Goikoetxea","doi":"10.1007/s40521-023-00345-6","DOIUrl":"https://doi.org/10.1007/s40521-023-00345-6","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"1 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2023-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43020634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of Epicutaneous Tests in the Study of Drug Allergy 经皮试验在药物过敏研究中的应用
IF 1.1
Current Treatment Options in Allergy Pub Date : 2023-07-05 DOI: 10.1007/s40521-023-00347-4
J. García-Abujeta, P. Iriarte, M. A. Gonzalo-Garijo, L. de las Vecillas, Marta Bernaola
{"title":"Use of Epicutaneous Tests in the Study of Drug Allergy","authors":"J. García-Abujeta, P. Iriarte, M. A. Gonzalo-Garijo, L. de las Vecillas, Marta Bernaola","doi":"10.1007/s40521-023-00347-4","DOIUrl":"https://doi.org/10.1007/s40521-023-00347-4","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43521440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Updates in the Role of Biologics in Asthma 生物制剂在哮喘中的作用的最新进展
IF 1.1
Current Treatment Options in Allergy Pub Date : 2023-06-20 DOI: 10.1007/s40521-023-00344-7
A. Sutherland, K. Keniston, V. Wang, J. Yusin
{"title":"Updates in the Role of Biologics in Asthma","authors":"A. Sutherland, K. Keniston, V. Wang, J. Yusin","doi":"10.1007/s40521-023-00344-7","DOIUrl":"https://doi.org/10.1007/s40521-023-00344-7","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"1 1","pages":""},"PeriodicalIF":1.1,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"52820015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevention and Treatment of COVID-19-Associated Mucormycosis covid -19相关毛霉病的预防和治疗
IF 1.1
Current Treatment Options in Allergy Pub Date : 2023-06-01 DOI: 10.1007/s40521-023-00339-4
Kevin T. Grafmiller, Jivianne T. Lee
{"title":"Prevention and Treatment of COVID-19-Associated Mucormycosis","authors":"Kevin T. Grafmiller, Jivianne T. Lee","doi":"10.1007/s40521-023-00339-4","DOIUrl":"https://doi.org/10.1007/s40521-023-00339-4","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"10 1","pages":"83 - 92"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41896149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute and Chronic Urticaria Diagnosis and Management Taking into Account Their Differences 急性和慢性荨麻疹的诊断和治疗的差异
IF 1.1
Current Treatment Options in Allergy Pub Date : 2023-06-01 DOI: 10.1007/s40521-023-00333-w
A. Salman, Nasser Mohammad Porras, A. Gimenez-Arnau
{"title":"Acute and Chronic Urticaria Diagnosis and Management Taking into Account Their Differences","authors":"A. Salman, Nasser Mohammad Porras, A. Gimenez-Arnau","doi":"10.1007/s40521-023-00333-w","DOIUrl":"https://doi.org/10.1007/s40521-023-00333-w","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"10 1","pages":"130 - 147"},"PeriodicalIF":1.1,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45524453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Food Allergy: Emerging Therapies 食物过敏:新兴疗法
IF 1.1
Current Treatment Options in Allergy Pub Date : 2023-05-31 DOI: 10.1007/s40521-023-00343-8
Ashna Mehra, R. Grohman, Sohini S. Shah, A. Nowak‐Wegrzyn
{"title":"Food Allergy: Emerging Therapies","authors":"Ashna Mehra, R. Grohman, Sohini S. Shah, A. Nowak‐Wegrzyn","doi":"10.1007/s40521-023-00343-8","DOIUrl":"https://doi.org/10.1007/s40521-023-00343-8","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47636020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Innate Immune Cells in Allergen Immunotherapy 天然免疫细胞在过敏原免疫治疗中的作用
IF 1.1
Current Treatment Options in Allergy Pub Date : 2023-05-30 DOI: 10.1007/s40521-023-00337-6
Jin Liu, Wen-jing Li, R. Zhu
{"title":"The Role of Innate Immune Cells in Allergen Immunotherapy","authors":"Jin Liu, Wen-jing Li, R. Zhu","doi":"10.1007/s40521-023-00337-6","DOIUrl":"https://doi.org/10.1007/s40521-023-00337-6","url":null,"abstract":"","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":"10 1","pages":"148 - 165"},"PeriodicalIF":1.1,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46831148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Drug-Induced Kounis Syndrome: Latest Novelties. 药物诱导的库尼斯综合征：最新研究。
IF 1.1
Current Treatment Options in Allergy Pub Date : 2023-05-30 DOI: 10.1007/s40521-023-00342-9
Paula Ollo-Morales, Marta Gutierrez-Niso, Elena De-la-Viuda-Camino, Marina Ruiz-de-Galarreta-Beristain, Ixone Osaba-Ruiz-de-Alegria, Carlota Martel-Martin
{"title":"Drug-Induced Kounis Syndrome: Latest Novelties.","authors":"Paula Ollo-Morales,&nbsp;Marta Gutierrez-Niso,&nbsp;Elena De-la-Viuda-Camino,&nbsp;Marina Ruiz-de-Galarreta-Beristain,&nbsp;Ixone Osaba-Ruiz-de-Alegria,&nbsp;Carlota Martel-Martin","doi":"10.1007/s40521-023-00342-9","DOIUrl":"10.1007/s40521-023-00342-9","url":null,"abstract":"<p><p>Kounis syndrome (KS) is defined by an acute coronary syndrome associated with hypersensitivity reactions, an under-diagnosed life-threatening medical emergency. Although multiple causes have been described, drugs constitute the most frequent cause. The purpose of this review is to update knowledge about drug-induced KS, to give guidelines on the correct diagnosis and treatment. This article reviews the literature on drug-induced KS from the last 5 years. Antibiotics and NSAIDs are the most frequently implicated drugs. In addition, data on pathophysiology, clinical presentation, diagnosis, and management are reviewed in detail. Highlight that there is a great deal of variability in the diagnosis and especially in the treatment of KS. This review provides a valuable selection of practical resources for all stakeholders to support effective care for KS, from a cardiologic and allergologic point of view. Future research should focus on developing validated, evidence-based, and patient-centered tools to improve the management of KS.</p>","PeriodicalId":36209,"journal":{"name":"Current Treatment Options in Allergy","volume":" ","pages":"1-18"},"PeriodicalIF":1.1,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10647398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信